Targeting PSGL-1/P-Selectin Interactions as a Novel Therapy for Metabolic Syndrome
Abstract Obesity-induced insulin resistance and metabolic syndrome continue to pose an important public health challenge worldwide as they significantly increase the risk of type 2 diabetes and atherosclerotic cardiovascular disease. Advances in the pathophysiologic understanding of this process has...
Gespeichert in:
Veröffentlicht in: | Translational research : the journal of laboratory and clinical medicine 2016-12, Vol.183, p.1-13 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!